These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34089144)

  • 1. Comparison of opioid prescribing upon hospital discharge in patients receiving tapentadol versus oxycodone following orthopaedic surgery.
    Wang X; Tay HP; Narayan SW; Penm J; Patanwala AE
    Int J Clin Pharm; 2021 Dec; 43(6):1602-1608. PubMed ID: 34089144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Adverse Events in Hospitalized Patients Following Orthopedic Surgery: Tapentadol Immediate Release Versus Oxycodone Immediate Release.
    Wang X; Narayan SW; Penm J; Johnstone C; Patanwala AE
    Pain Physician; 2021 May; 24(3):E309-E315. PubMed ID: 33988952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone.
    Lam T; Xia T; Biggs N; Treloar M; Cheng O; Kabu K; Stevens JA; Evans JD; da Gama ME; Lubman DI; Nielsen S
    Anaesthesia; 2023 Apr; 78(4):420-431. PubMed ID: 36535726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries.
    Wang X; Penm J; Patanwala AE
    Curr Med Res Opin; 2022 Jan; 38(1):115-121. PubMed ID: 34641744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
    Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
    BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapentadol Versus Oxycodone for Opioid-Related Adverse Drug Events and Clinical Outcomes After Inpatient Surgery.
    Liu S; Patanwala AE; Naylor JM; Stevens JA; Bugeja B; Begley D; Khor KE; Lau E; Adie S; Penm J
    J Pain; 2024 Feb; 25(2):466-475. PubMed ID: 37741523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative opioids administered to inpatients with major or orthopaedic surgery: A retrospective cohort study using data from hospital electronic prescribing systems.
    Huang YT; Dixon WG; O'Neill TW; Jani M
    PLoS One; 2024; 19(6):e0305531. PubMed ID: 38917135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
    Cepeda MS; Fife D; Ma Q; Ryan PB
    J Pain; 2013 Oct; 14(10):1227-41. PubMed ID: 23850177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.
    Vorsanger GJ; Klopfer AM; Xiang J; Benson CJ; Moskovitz BL; Rosenthal NR
    J Opioid Manag; 2013; 9(4):281-90. PubMed ID: 24353022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery .
    Stegmann JU; Weber H; Steup A; Okamoto A; Upmalis D; Daniels S
    Curr Med Res Opin; 2008 Nov; 24(11):3185-96. PubMed ID: 18851776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
    Lam T; Biggs N; Xia T; Evans J; Stevens J; da Gama M; Lubman DI; Nielsen S
    BMJ Open; 2022 Apr; 12(4):e060151. PubMed ID: 35418442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
    Vorsanger G; Xiang J; Okamoto A; Upmalis D; Moskovitz B
    J Opioid Manag; 2010; 6(3):169-79. PubMed ID: 20642246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G; Xiang J; Biondi D; Upmalis D; Delfgaauw J; Allard R; Moskovitz B
    Pain Res Manag; 2011; 16(4):245-51. PubMed ID: 22059194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
    Daniels S; Casson E; Stegmann JU; Oh C; Okamoto A; Rauschkolb C; Upmalis D
    Curr Med Res Opin; 2009 Jun; 25(6):1551-61. PubMed ID: 19445652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures.
    Sabatino MJ; Kunkel ST; Ramkumar DB; Keeney BJ; Jevsevar DS
    J Bone Joint Surg Am; 2018 Feb; 100(3):180-188. PubMed ID: 29406338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
    Eichenbaum G; Göhler K; Etropolski M; Steigerwald I; Pergolizzi J; Kim M; Vorsanger G
    J Opioid Manag; 2015; 11(3):211-27. PubMed ID: 25985806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
    Hale M; Upmalis D; Okamoto A; Lange C; Rauschkolb C
    Curr Med Res Opin; 2009 May; 25(5):1095-104. PubMed ID: 19301989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
    Kwong WJ; Hammond G; Upmalis D; Okamoto A; Yang M; Kavanagh S
    Clin J Pain; 2013 Aug; 29(8):664-72. PubMed ID: 23835764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.